QL
LENZ

Quarry LP’s LENZ Therapeutics LENZ Stock Holding History

Quarry LP’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$273 Buy
+48
New +$387 ﹤0.01% 2254
2025
Q4 		– Sell
-577
Closed -$26.9K – 2700
2025
Q3 		$26.9K Buy
+577
New +$21.2K 0.01% 1223

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Quarry LP's LENZ Position: Q2 2026 in Review

Quarry LP opened a new position in LENZ Therapeutics (LENZ) in Q2 2026: 48 shares worth $273. The stake represents ﹤0.01% of the portfolio and ranks #2254 among its holdings. This is a return to the name: Quarry LP previously reported a position in LENZ as recently as Q3 2025.

Quarry LP first reported a position in LENZ in Q3 2025 and has held it in 2 quarters since. The position peaked at $26.9K in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Quarry LP held 48 shares of LENZ Therapeutics worth $273 as of Q2 2026.
  • LENZ Therapeutics was a new Quarry LP position in Q2 2026.
  • LENZ Therapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #2254 holding.
  • Quarry LP first reported a position in LENZ Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • Quarry LP's LENZ Therapeutics position peaked at $26.9K in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.